Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

FDA grants QIDP designation to iclaprim for hospital-acquired pneumonia

July 17, 2015

Achaogen receives NIAID contract to develop novel antibacterials

July 17, 2015

IRM divulges antiparasitic agents

July 16, 2015

Initiation of phase II study of Ad26.ZEBOV and MVA-BN-Filo Ebola prime-boost vaccine regimen

July 16, 2015

Eligo Bioscience's development of antibiotics supported by new investment

July 14, 2015

Benitec acquires full rights to Hepbarna hepatitis B program

July 13, 2015

Bristol-Myers Squibb presents HCV NS5B inhibitors

July 13, 2015

FDA clears phase IIa study of AR-301 in acute pneumonia to expand into U.S.

July 10, 2015

Vaccine candidate LT-69 confers long-term protection against M. tuberculosis infection in mice

July 10, 2015

Immunovaccine and PharmAthene to develop anthrax vaccine formulated in DepoVax

July 10, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...